ETON

Eton Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Brynjelsen SeanDirector, 10 Percent Owner, Officer: President & CEO
$1.2M70k shares
SellJun 5, 2025
$16.81
--
Brynjelsen SeanDirector, 10 Percent Owner, Officer: President & CEO
$1.2M70k shares
SellJun 4, 2025
$17.00
--
Brynjelsen SeanDirector, 10 Percent Owner, Officer: President & CEO
$7.6k400 shares
SellJun 3, 2025
$19.02
--
Brynjelsen SeanDirector, 10 Percent Owner, Officer: President & CEO
$159k8.7k shares
SellJun 3, 2025
$18.38
--
Brynjelsen SeanDirector, 10 Percent Owner, Officer: President & CEO
$1.1M60.9k shares
SellJun 3, 2025
$17.38
--
Krempa DavidChief Business Officer
$151k10.2k shares
SellJun 16, 2025
$14.73
--

News

gurufocus.comEton Pharmaceuticals Inc (ETON) Shares Fall 4.3% -- What GF Score of 70 Tells Investorsgurufocus.comMay 29globenewswire.comEton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)globenewswire.comMay 19seekingalpha.comEton Pharmaceuticals, Inc. (ETON) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 14marketbeat.comEton Pharmaceuticals Q1 Earnings Call Highlightsmarketbeat.comMay 14zacks.comEton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimateszacks.comMay 14